Cargando…

Prognostic and predictive value of radiomics features at MRI in nasopharyngeal carcinoma

PURPOSE: To explore the value of MRI-based radiomics features in predicting risk in disease progression for nasopharyngeal carcinoma (NPC). METHODS: 199 patients confirmed with NPC were retrospectively included and then divided into training and validation set using a hold-out validation (159: 40)....

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Dan, Zhao, Yanfeng, Liu, Zhou, Zhong, Hongxia, Geng, Yayuan, Lin, Meng, Li, Lin, Zhao, Xinming, Luo, Dehong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683387/
https://www.ncbi.nlm.nih.gov/pubmed/34993528
http://dx.doi.org/10.1007/s12672-021-00460-3
_version_ 1784617406911479808
author Bao, Dan
Zhao, Yanfeng
Liu, Zhou
Zhong, Hongxia
Geng, Yayuan
Lin, Meng
Li, Lin
Zhao, Xinming
Luo, Dehong
author_facet Bao, Dan
Zhao, Yanfeng
Liu, Zhou
Zhong, Hongxia
Geng, Yayuan
Lin, Meng
Li, Lin
Zhao, Xinming
Luo, Dehong
author_sort Bao, Dan
collection PubMed
description PURPOSE: To explore the value of MRI-based radiomics features in predicting risk in disease progression for nasopharyngeal carcinoma (NPC). METHODS: 199 patients confirmed with NPC were retrospectively included and then divided into training and validation set using a hold-out validation (159: 40). Discriminative radiomic features were selected with a Wilcoxon signed-rank test from tumors and normal masticatory muscles of 37 NPC patients. LASSO Cox regression and Pearson correlation analysis were applied to further confirm the differential expression of the radiomic features in the training set. Using the multiple Cox regression model, we built a radiomic feature-based classifier, Rad-Score. The prognostic and predictive performance of Rad-Score was validated in the validation cohort and illustrated in all included 199 patients. RESULTS: We identified 1832 differentially expressed radiomic features between tumors and normal tissue. Rad-Score was built based on one radiomic feature: CET1-w_wavelet.LLH_GLDM_Dependence-Entropy. Rad-Score showed a satisfactory performance to predict disease progression in NPC with an area under the curve (AUC) of 0.604, 0.732, 0.626 in the training, validation, and the combined cohort (all 199 patients included) respectively. Rad-Score improved risk stratification, and disease progression-free survival was significantly different between these groups in every cohort of patients (p = 0.044 or p < 0.01). Combining radiomics and clinical features, higher AUC was achieved of the prediction of 3-year disease progression-free survival (PFS) (AUC, 0.78) and 5-year disease PFS (AUC, 0.73), although there was no statistical difference. CONCLUSION: The radiomics classifier, Rad-Score, was proven useful for pretreatment prognosis prediction and showed potential in risk stratification for NPC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12672-021-00460-3.
format Online
Article
Text
id pubmed-8683387
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-86833872022-01-04 Prognostic and predictive value of radiomics features at MRI in nasopharyngeal carcinoma Bao, Dan Zhao, Yanfeng Liu, Zhou Zhong, Hongxia Geng, Yayuan Lin, Meng Li, Lin Zhao, Xinming Luo, Dehong Discov Oncol Research PURPOSE: To explore the value of MRI-based radiomics features in predicting risk in disease progression for nasopharyngeal carcinoma (NPC). METHODS: 199 patients confirmed with NPC were retrospectively included and then divided into training and validation set using a hold-out validation (159: 40). Discriminative radiomic features were selected with a Wilcoxon signed-rank test from tumors and normal masticatory muscles of 37 NPC patients. LASSO Cox regression and Pearson correlation analysis were applied to further confirm the differential expression of the radiomic features in the training set. Using the multiple Cox regression model, we built a radiomic feature-based classifier, Rad-Score. The prognostic and predictive performance of Rad-Score was validated in the validation cohort and illustrated in all included 199 patients. RESULTS: We identified 1832 differentially expressed radiomic features between tumors and normal tissue. Rad-Score was built based on one radiomic feature: CET1-w_wavelet.LLH_GLDM_Dependence-Entropy. Rad-Score showed a satisfactory performance to predict disease progression in NPC with an area under the curve (AUC) of 0.604, 0.732, 0.626 in the training, validation, and the combined cohort (all 199 patients included) respectively. Rad-Score improved risk stratification, and disease progression-free survival was significantly different between these groups in every cohort of patients (p = 0.044 or p < 0.01). Combining radiomics and clinical features, higher AUC was achieved of the prediction of 3-year disease progression-free survival (PFS) (AUC, 0.78) and 5-year disease PFS (AUC, 0.73), although there was no statistical difference. CONCLUSION: The radiomics classifier, Rad-Score, was proven useful for pretreatment prognosis prediction and showed potential in risk stratification for NPC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12672-021-00460-3. Springer US 2021-12-17 /pmc/articles/PMC8683387/ /pubmed/34993528 http://dx.doi.org/10.1007/s12672-021-00460-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Bao, Dan
Zhao, Yanfeng
Liu, Zhou
Zhong, Hongxia
Geng, Yayuan
Lin, Meng
Li, Lin
Zhao, Xinming
Luo, Dehong
Prognostic and predictive value of radiomics features at MRI in nasopharyngeal carcinoma
title Prognostic and predictive value of radiomics features at MRI in nasopharyngeal carcinoma
title_full Prognostic and predictive value of radiomics features at MRI in nasopharyngeal carcinoma
title_fullStr Prognostic and predictive value of radiomics features at MRI in nasopharyngeal carcinoma
title_full_unstemmed Prognostic and predictive value of radiomics features at MRI in nasopharyngeal carcinoma
title_short Prognostic and predictive value of radiomics features at MRI in nasopharyngeal carcinoma
title_sort prognostic and predictive value of radiomics features at mri in nasopharyngeal carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683387/
https://www.ncbi.nlm.nih.gov/pubmed/34993528
http://dx.doi.org/10.1007/s12672-021-00460-3
work_keys_str_mv AT baodan prognosticandpredictivevalueofradiomicsfeaturesatmriinnasopharyngealcarcinoma
AT zhaoyanfeng prognosticandpredictivevalueofradiomicsfeaturesatmriinnasopharyngealcarcinoma
AT liuzhou prognosticandpredictivevalueofradiomicsfeaturesatmriinnasopharyngealcarcinoma
AT zhonghongxia prognosticandpredictivevalueofradiomicsfeaturesatmriinnasopharyngealcarcinoma
AT gengyayuan prognosticandpredictivevalueofradiomicsfeaturesatmriinnasopharyngealcarcinoma
AT linmeng prognosticandpredictivevalueofradiomicsfeaturesatmriinnasopharyngealcarcinoma
AT lilin prognosticandpredictivevalueofradiomicsfeaturesatmriinnasopharyngealcarcinoma
AT zhaoxinming prognosticandpredictivevalueofradiomicsfeaturesatmriinnasopharyngealcarcinoma
AT luodehong prognosticandpredictivevalueofradiomicsfeaturesatmriinnasopharyngealcarcinoma